Clinical News & Alerts

Sleep, exercise, hydrate – do we really need to stick to recommended daily doses?

Abrysvo▼ (Pfizer RSV vaccine) and Arexvy▼ (GSK RSV vaccine): be alert to a small risk of Guillain-Barré syndrome following vaccination in older adults

Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): updated safety and educational materials to support patient discussion on reproductive risks

Thiopurines and intrahepatic cholestasis of pregnancy

Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor): risk of psychological side effects

Short-acting beta 2 agonists (SABA) (salbutamol and terbutaline): reminder of the risks from overuse in asthma and to be aware of changes in the SABA prescribing guidelines

Fezolinetant▼(Veoza): risk of liver injury; new recommendations to minimise risk

Prolonged-release opioids: Removal of indication for relief of post-operative pain

Letters and medicine recalls sent to healthcare professionals in January 2025

Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): review by two specialists is required for initiating valproate but not for male patients already taking valproate